PCRX Cash & Short-Term Investments
Pacira Biosciences Inc · Cash & Short-Term Investments
PCRX Cash & Short-Term Investments
Latest reported$238.42Mperiod ending
PCRX FY Cash & Short-Term Investments ($12.39M → $238.42M)
Annual Cash & Short-Term Investments
High-resolution chart · PNG
PCRX cash & short-term investments history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 238,424,000 | |
| 484,615,000 | |
| 278,581,000 | |
| 288,651,000 | |
| 656,409,000 | |
| 521,662,000 | |
| 291,950,000 | |
| 383,454,000 | |
| 311,347,000 | |
| 172,597,000 | |
| 158,965,000 | |
| 158,167,000 | |
| 72,152,000 | |
| 42,573,000 | |
| 76,153,000 | |
| 26,133,000 | |
| 7,077,000 | |
| 12,386,000 |